Analiz Rodriguez Source Confirmed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
University of Arkansas for Medical Sciences
faculty
Neurosurgery, College of Medicine
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Analiz Rodriguez, an Associate Professor in Neurosurgery at the University of Arkansas for Medical Sciences, focuses her research on the development and application of novel therapeutic strategies for glioblastoma and other solid tumors. Her work utilizes advanced models, including patient-derived organoids and zebrafish cancer avatars, to investigate tumor heterogeneity and predict treatment outcomes. Rodriguez is a principal investigator on federal grants, including a $76,500 award from the NIH/National Cancer Institute for the development of immunocompetent melanoma brain metastases organoids.
Her recent publications highlight her engagement with cutting-edge treatments such as oncolytic virotherapy, CAR-T cell therapies, and precision medicine pipelines that combine transcriptomics with organoid modeling. She has investigated the efficacy of specific compounds like monensin in glioblastoma models and explored the potential of CAR T-cells for treating brain tumors. Rodriguez's scholarship is recognized by her high-impact researcher designation, evidenced by an h-index of 26 and over 7,480 citations across her 182 publications.
Rodriguez actively collaborates with researchers within the University of Arkansas for Medical Sciences, including Murat Gökden, Megan R. Reed, Annick De Loose, and Robert L. Eoff, with whom she has co-authored multiple publications. She maintains an active laboratory website to disseminate her research findings.
Metrics
- h-index: 26
- Publications: 182
- Citations: 7,480
Selected Publications
- Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial (2025) DOI
- Interstitial Thermal Therapy in Mesial Temporal Lobe Epilepsy (2025) DOI
- Integrating the SDGs into Urban Regeneration: A Madrid Nuevo Norte Case Study Using an Adapted Voluntary Local Review Framework (2024) DOI
- Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyond (2024) DOI
- Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma (2024) DOI
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case (2024) DOI
- Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases (2024) DOI
- Long-read sequencing for brain tumors (2024) DOI
- SMARCA4-deficient central nervous system metastases: A case series and systematic review (2024) DOI
- A rare case of atypical intradural extramedullary glioblastoma diagnosed utilizing next-generation sequencing and methylation profiling: illustrative case (2024) DOI
- Laser interstitial thermal therapy for new and recurrent meningioma: a prospective and retrospective case series (2024) DOI
- Synthesis and Anti‐Melanoma Activity of Acryloyl Pyridinone Analogues (2023) DOI
- CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL (2023) DOI
- 1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma (2023) DOI
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma (2023) DOI
Federal Grants 1 $76,500 total
Development of immunocompetent melanoma brain metastases organoids
Grants & Funding
- A Phase IlI Clinical Trial Evaluating DCVax-L, Autologous Dendritis Cells Pulsed Northwest Biotherapeutics, Inc. Principal Investigator
- Development of immunocompetent melanoma brain metastases organoids NIH/Nat. Cancer Institute Principal Investigator
- A Phase IlI Clinical Trial Evaluating DCVax-L, Autologous Dendritis Cells Pulsed Northwest Biotherapeutics, Inc. Principal Investigator
- Development of immunocompetent melanoma brain metastases organoids NIH/Nat. Cancer Institute Principal Investigator
- No FP attached UAMS Internal Research Awards Principal Investigator
- Photobiomodulation to Ameliorate Neuronal Degeneration and Cognitive Decline after Mixed Field Irradiation - Continuation National Aeronautics & Space Administration Co-Investigator
- Center for Studies of Host Response to Cancer Therapy NIH Co-Investigator
- Novel Platform linking cancer-specific glycosylation with cell signaling outcomes NIH Co-Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics